Ingevity Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Portfolio Pulse from Benzinga Insights
Ingevity (NYSE:NGVT) received mixed analyst ratings in the last quarter, with a shift towards a more cautious stance in the last 30 days. The average 12-month price target for NGVT has been raised to $56.5, reflecting a 16.49% increase from the previous target. Analysts from Loop Capital, Oppenheimer, Jefferies, and Wells Fargo have all raised their price targets, indicating a positive outlook on the stock despite the company facing challenges such as a -13.37% decline in revenue growth and a high debt-to-equity ratio of 2.74.
May 07, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ingevity's stock received mixed ratings from analysts, with an updated average price target of $56.5. Despite facing revenue decline and high debt, the raised price targets suggest a cautiously optimistic outlook.
The increase in the average price target to $56.5, despite Ingevity's revenue decline and high debt levels, indicates analysts' belief in the company's potential for recovery and growth. The mixed ratings reflect a cautious but optimistic view, suggesting that while there are significant challenges, there are also factors that could drive the stock's performance positively in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100